Biodelivery Sciences
Biodelivery Sciences
WKN: 766464 / Symbol: BDSI / Name: Biodelivery Sci / Aktie / Pharmazeutika / Small Cap /
5,05 €
-0,98 %
The company continues to show impressive growth in BELBUCA scripts and sales. Recently acquired Symproic also seems to be off to a good start in the hand of BioDelivery as well. The company is on its way to achieving cash flow positive status by the close of this year. Selling at less than one times the eventual annual sales management believes it can achieve with BELBUCA and Symprioc, the shares remain cheap.
Buy Biodelivery Sciences
Kursziel geändert auf 6,0
Kursziel geändert auf 6,0
Kursziel geändert auf 6,5
Kursziel geändert auf 7,0
Sell Biodelivery Sciences
Sell Biodelivery Sciences
Sell Biodelivery Sciences
Buy mit Kursziel 4,0
Sell Biodelivery Sciences
Sell Biodelivery Sciences
Neueste Beiträge
fenjal in Nagarro SE diskutieren